Biomarkers and Precision Medicine Community (BPMC)

Please join for an Open Scientific Discussion (OSD) hosted by the AAPS Biomarkers and Precision Medicine (BPM) Community on October 2^nd, 12 – 1 pm EST on the following topic:

Considerations for Biomarker Strategy Implementation in a Drug Development Program (Part 1)

• When and how do you start setting biomarker strategy?  What is the team composition?
• How does strategy change as a drug progresses through development?
• Brief overview of the types of biomarkers and Context of Use
• Perspective and approaches from different companies

Discussion Leaders:

• Lakshmi Amaravadi (AstraZeneca)
• Michele Gunsior (Astria Therapeutics)
• Christopher Stroh (Merck Healthcare KGaA)

Organized by:  Karen Quadrini (Prothena Biosciences), Carmen Fernández-Metzler (PharmaCadence), Kyra Cowan (Merck Healthcare KGaA)

When: Wednesday, Oct. 2, 2024 12pm – 1pm EST

Where: Please join from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/305789893

#Biomarkers
#strategy